Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

Ark Funds launched the Ark Innovation and Ark Genomic ETFs on Oct. 31, 2014. A look at how the ETFs have performed since their launch and how the returns compare to the S&P 500. Ark Funds ...

Asset manager ARK Invest may have just sold a sizeable amount of shares in Jack Dorsey’s financial services company Block Inc ...

Antero Resources (NYSE:AR – Get Free Report ... $27.47 and its 200-day simple moving average is $30.29. 10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 ...

Here is what makes this ETF so good. When you buy the Schwab U.S. Dividend Equity ETF, that work is done for you and only costs you an expense ratio of 0.06%. You're getting a well-diversified ...

20:18 EDT Cathie Wood’s ARK Investment buys 193K shares of Cerus (CERS) today Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now ...

Tesla has an Earnings ESP of -1.28% and a Zacks Rank #2 (Buy). According to our methodology ... charging 86 bps in annual fees. ARK Innovation ETF (ARKK) ARK Innovation ETF is an actively ...

Ashton Thomas Private Wealth LLC purchased a new position in ARK Innovation ETF during the 2nd quarter valued at $26,000. Westside Investment Management Inc. raised its stake in ARK Innovation ETF ...

They aren’t designed for buy-and-hold investors. They definitely shouldn’t be used by risk-averse investors. The fact that ETF providers continue to produce single-stock ETFs suggests a market ...

Ark's flagship Innovation ETF realized $3.5 billion in losses from July 31, 2023, through July 31, 2024. Across Ark's suite of eight innovation and disruption-focused ETFs, the total accumulated ...